Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study

BACKGROUND: The survival benefit of re-resection for glioblastoma (GBM) remains controversial, owing to the immortal time bias inadequately considered in many studies where re-resection was treated as a fixed, rather than a time-dependent factor. Using the Surveillance, Epidemiology, and End Results...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Debra A, Reiner, Anne S, Diamond, Eli L, DeAngelis, Lisa M, Tabar, Viviane, Panageas, Katherine S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813163/
https://www.ncbi.nlm.nih.gov/pubmed/33506202
http://dx.doi.org/10.1093/noajnl/vdaa159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813163/
https://www.ncbi.nlm.nih.gov/pubmed/33506202
http://dx.doi.org/10.1093/noajnl/vdaa159

Ejemplares similares